{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-024817","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2023-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.300220+00:00","generated_at":"2026-06-14T11:58:45.958136+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Rani Therapeutics annual meeting elects all director nominees; ratifies Ernst & Young as auditor","bullets":["All 8 director nominees elected with substantial support; votes for each exceeded 226M, with withheld votes under 200K.","Ratification of Ernst & Young as independent auditor passed: 230,587,049 for, 51 against, 2,301 abstain.","Record date March 30, 2023: 25.4M Class A shares (1 vote each) and 24.1M Class B shares (10 votes each) outstanding.","No other proposals were considered; all matters approved as recommended by the board."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-024817","json":"https://secwatch.observer/filing/0000950170-23-024817.json","markdown":"https://secwatch.observer/filing/0000950170-23-024817.md","text":"https://secwatch.observer/filing/0000950170-23-024817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023024817/0000950170-23-024817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023024817/rani-20230525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T11:58:45.958136+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1247d68792da8fbef4f57350990d5e4943d24db2","claim":"Rani Therapeutics Holdings, Inc. shareholders approved Ratification of the selection of Ernst & Young, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-05-25 meeting.","evidence_excerpt":"The Company’s stockholders ratified the selection of Ernst & Young, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, as follows: For: 230,587,049 Against: 51 Abstain: 2,301","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023024817/0000950170-23-024817-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"3173d0007d1d29250672c45fd754c891c469aba9","claim":"Rani Therapeutics Holdings, Inc. shareholders approved Election of director nominees to hold office until the 2024 annual meeting of stockholders at the 2023-05-25 meeting.","evidence_excerpt":"The Company’s stockholders elected the director nominees below, to hold office until the 2024 annual meeting of stockholders or until their successors are duly elected and qualified, as follows: For Withheld Broker Non-Votes Talat Imran 226,312,911 27,468 4,249,022 Mir Imran 226,125,068 215,311 4,249,022 Dennis Ausiello 226,152,615 187,764 4,249,022 Jean-Luc Butel 226,144,055 196,324 4,249,022 Laureen DeBuono 226,292,924 47,455 4,249,022 Andrew Farquharson 226,277,448 62,931 4,249,022 Malik Nanavaty 226,292,189 48,190 4,249,022 Lisa Rometty 226,314,568 25,811 4,249,022","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023024817/0000950170-23-024817-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}